Iol Chemicals And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 80.00 Cr
- Paid Up Capital ₹ 58.71 Cr
- Company Age 38 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 600.00 Cr
- Satisfied Charges ₹ 1,487.01 Cr
- Revenue Growth 1.20%
- Profit Growth -15.50%
- Ebitda -11.61%
- Net Worth 8.36%
- Total Assets 3.08%
About Iol Chemicals And Pharmaceuticals
Iol Chemicals And Pharmaceuticals Limited (ICAPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 29 September 1986 and has a history of 38 years and four months. Its registered office is in Barnala, Punjab, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524164 and on the National Stock Exchange(NSE) under IOLCP.
The Corporate was formerly known as Trident Alco-Chem Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 80.00 Cr and a paid-up capital of Rs 58.71 Cr.
The company currently has active open charges totaling ₹600.00 Cr. The company has closed loans amounting to ₹1,487.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Iol Chemicals And Pharmaceuticals Limited India are Vikas Vij as Ceo, Pardeep Khanna as Cfo, and Abhay Singh as Company Secretary. Varinder Gupta, Rajender Malla, Sharad Tyagi, and Five other members serve as directors at the Company.
Company Details
- Location
Barnala, Punjab, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
Industry
What products or services does Iol Chemicals And Pharmaceuticals Limited offer?
Iol Chemicals And Pharmaceuticals Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Blood System and Cardiovascular API, Nervous System and Antipsychotic API.
Who are the key members and board of directors at Iol Chemicals And Pharmaceuticals?
Executive Team (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Varinder Gupta ![]() | Managing Director | 13-Nov-1986 | Current |
Vikas Vij | CEO | 03-Apr-2023 | Current |
Pardeep Khanna ![]() | CFO | 13-Aug-2015 | Current |
Abhay Singh ![]() | Company Secretary | 14-Nov-2019 | Current |
Board Members (7)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kushal Rana ![]() | Whole-Time Director | 04-Jun-2021 | Current |
Harpal Singh ![]() | Director | 06-Feb-2019 | Current |
Sandhya Mehta ![]() | Director | 22-Aug-2014 | Current |
Rajender Malla ![]() | Director | 06-Feb-2019 | Current |
Sharad Tyagi ![]() | Director | 30-May-2022 | Current |
Vikas Gupta ![]() | Whole-Time Director | 29-May-2015 | Current |
Financial Performance of Iol Chemicals And Pharmaceuticals.
Iol Chemicals And Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.2% increase. The company also saw a substantial fall in profitability, with a 15.5% decrease in profit. The company's net worth moved up by a moderate rise of 8.36%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Iol Chemicals And Pharmaceuticals?
In 2023, Iol Chemicals And Pharmaceuticals had a promoter holding of 48.19% and a public holding of 51.81%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹600.00 Cr
₹1,487.01 Cr
Charges Breakdown by Lending Institutions
- Others : 600.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
21 Jun 2016 | Others | ₹600.00 Cr | Open |
31 May 2016 | Others | ₹15.00 Cr | Satisfied |
23 Mar 2015 | Others | ₹30.71 Cr | Satisfied |
31 Dec 2014 | Punjab National Bank | ₹65.12 Cr | Satisfied |
30 Jun 2014 | Punjab National Bank | ₹162.40 Cr | Satisfied |
How Many Employees Work at Iol Chemicals And Pharmaceuticals?
Iol Chemicals And Pharmaceuticals has a workforce of 2778 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Iol Chemicals And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iol Chemicals And Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.